A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson's Disease

CONCLUSION: Applying a Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach to summarize the evidence, we found moderate confidence in the body of evidence for the efficacy of rasagiline or pramipexole in early PD, suggesting further well-designed, multicenter comparative RCTs remain needed.PMID:38264500 | PMC:PMC10805557 | DOI:10.1155/2024/8448584

Source: Parkinsons Disease - January 24, 2024 Category: Neurology Authors: Pauli Sepp änen Markus M Forsberg Miia Tiihonen Heikki Laitinen Selena Beal David C Dorman Source Type: research